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Abstract
Background: Reduced heart rate variability (HRV), a non-invasive marker of autonomic dysfunction, and an
unhealthy lifestyle are associated with an increased morbidity and mortality of cardiovascular diseases (CVD). The
autonomic dysfunction is a potential mediator of the association of behavioural risk factors with adverse health
outcomes. We studied the association of HRV with behavioural risk factors in an elderly population.
Methods: This analysis was based on the cross-sectional data of 1671 participants (age range, 45-83 years) of the
prospective, population-based Cardiovascular Disease, Living and Ageing in Halle (CARLA) Study. Physical activity,
smoking habits, alcohol consumption and dietary patterns were assessed in standardized interviews. Time and
frequency domain measures of HRV were computed from 5-min segments of highly standardized 20-min
electrocardiograms. Their association with behavioural risk factors was determined by linear and non-parametric
regression modelling.
Results: There were only weak and inconsistent associations of higher physical activity, moderate consumption of
alcohol, and non-smoking with higher time and frequency domain HRV in both sexes, and no association with
dietary pattern. Results changed only marginally by excluding subjects with CVD, diabetes mellitus and use of
cardioactive medication.
Conclusion: We hypothesized that HRV is associated with behavioural factors and therefore might be a mediator
of the effect of behavioural risk factors on CVD, but this hypothesis was not confirmed by our results. These
findings support the interpretation that there may be no true causal association of behavioural factors with HRV.
Background
Epidemiological studies provide evidence that a healthy
lifestyle (e.g., physical activity, not smoking, healthy diet,
and moderate consumption of alcohol) reduces morbid-
ity and mortality due to cardiovascular causes [1]. In
addition, reduced heart rate variability (HRV), a marker
of autonomic dysfunction, has been shown to be asso-
ciated with an increased risk of incident myocardial
infarction, cardiovascular mortality, and death from
other causes in general populations [2-4], and to be
associated with a poor prognosis of cardiovascular dis-
eases (CVD) [5,6]. Reduced HRV has been shown to be
related to risk factors for cardiovascular disease [7-13],
so autonomic dysfunction could be a mediator of the
association of cardiovascular risk factors with CVD.
There is some evidence that reduced HRV is amenable
to intervention that may improve future health out-
comes [14,15].
Several studies investigated the association of physical
activity and HRV, but results are inconsistent and diffi-
cult to compare due to differences in study populations,
differences in the assessment of physical activity or in
training regimes, differences in recording conditions of
the electrocardiograms (ECG) and due to methodologi-
cal problems inherent in the analysis of HRV
[9,11,15-21]. Furthermore, only few studies have ana-
lyzed the association of HRV with other behavioural risk
factors such as smoking [10,11,22-24], alcohol consump-
tion [10,11,23,25,26], and diet [10,25,27].
The Cardiovascular Disease, Living and Ageing in
Halle (CARLA) study is a large population-based study
with a comprehensive and highly standardized HRV
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measurement protocol. The aim of the present analyses
was to assess the association of behavioural risk factors
with HRV as the first step of the potential pathway to
CVD. We hypothesized that physical activity and a
favourable dietary pattern are directly associated with
HRV, smoking is associated with reduced HRV, and
alcohol consumption shows a nonlinear J-shaped asso-
ciation with HRV.
Methods
The present analyses are based on data from the base-
line examination of the prospective, population-based
CARLA study. Details of the study have been described
elsewhere [28,29]. In brief, the CARLA study is a pro-
spective cohort study of a representative sample of the
inhabitants of the city of Halle (Eastern Germany) com-
prising 1779 (812 females, 967 males) participants aged
45-83 years at baseline. The baseline examination took
place between December 2002 and January 2006.
The study protocol was approved by the Ethics Com-
mittee of the Martin Luther University Halle-Wittenberg
(Halle, Germany) and conforms to the tenets of the
Declaration of Helsinki. All participants were informed
about the study and written consent was obtained from
them.
The medical examination involved recording of: blood
pressure taken while seated; heart rate (HR) while seated
and lying down; circumference of the waist and hip;
weight and height; a 20-min 12-lead resting ECG (Car-
dioControl Working Station, Welch Allyn, Delft, the
Netherlands); and an echocardiogram. A venous blood
sample was also taken.
A standardized, computer-assisted interview was
undertaken to collect information on: socio-demo-
graphic and socio-economic variables; behavioural, bio-
medical and psychosocial factors; medical history; and
use of medication within the preceding 7 days.
Physical activity was recorded using the Baecke ques-
tionnaire, describing the typically physical activity during
the previous 12 months [30]. Being physically active at
sport was defined as giving an affirmative answer to the
question “Do you play sports?”. A sport index was calcu-
lated based on the intensity, frequency and duration of
sports activity [30]. Furthermore, physical activity during
leisure time (excluding sport) was summarized in the
leisure-time index. The total physical activity index was
calculated as the sum of the sports and leisure-time
index. Moreover, for the subset of participants who
were characterized as being physically active in sports,
we calculated the energy expenditure during sports
activities in metabolic equivalents (MET) [31]. Time
spent per week on each sporting activity was multiplied
by the MET value of the activity to give MET-hours per
week.
Information on smoking habits involved questions on:
past and current smoking status; duration of smoking;
and on the quantity of tobacco products smoked per
day. We used two continuous measures of smoking for
the present analyses, involving the number of: (i) cur-
rently smoked tobacco products per day; (ii) packyears
of tobacco products ever smoked.
Self-reported usual consumption of alcohol in g/day
was calculated from the answer to the questions “How
much beer (in units of 0.5 l)...”, “How much wine or
champagne (in units of 0.2 l)...”, and “How many glasses
of spirits (2 cl/glass)... do you usually drink during one
week?” The underlying concentration of alcohol was 4.8
volume-% for beer, 11.0 volume-% for wine or cham-
pagne, and 33.0 volume-% for spirits [32].
The mean dietary pattern during the previous 12
months was recorded by a validated food frequency
questionnaire [33]. The use of selected food groups was
classified according to the recommendations of the Ger-
man Society of Nutrition as used in the KORA-MON-
ICA Studies [33]. The classifications per food category
were coded in an overall summary score per subject,
which ranged from 0 (worst dietary pattern) to 30 (best
dietary pattern). A favourable dietary pattern is charac-
terized by a diet rich in carbohydrates (potatoes, pasta,
rice and whole-grain bread), vegetables and fruits.
The 20-min ECG was recorded after a resting period
(in the supine position) of ≥20 min. Throughout the
ECG, subjects were asked to breathe at 15 breaths/min
(0.25 Hz) - guided by a visual metronome - to standar-
dize the influence of the respiratory rate on spectral
HRV parameters.
All electrocardiograms were processed by the Modular
ECG Analysis System (MEANS) [34] to obtain the loca-
tion and type of the QRS complexes of the 20-min
ECG. This information was used to compute standard
time and frequency domain parameters of HRV for 5-
min segments of the ECG according to the current
guidelines for the analysis of HRV [35]. Artefacts and
ectopic beats were replaced by interpolated normal
sinus beats. We used the standard deviation of normal
intervals (SDNN) - a time domain parameter - and the
frequency domain parameters low frequency power (LF)
(0.04 to <0.15 Hz), high-frequency (HF) power (0.15-0.4
Hz), and the ratio of LF to HF (LF/HF). To calculate
frequency domain parameters, tachograms of RR inter-
vals were adjusted for linear trends, tapered and zero-
padded, and a Fast Fourier transformation was
employed. For further analyses, HRV derived from the
first 5-min segment of the 20-min ECG which fulfilled
the following quality criteria was used: <10% of abnor-
mal beats; stationarity of the tachogram; absence of
atrial fibrillation, atrial flutter, artificially paced beats
and other arrhythmias.
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The 5-min HRV for 1671 subjects (94% of 1777 parti-
cipants with a 20-min ECG) could be used for further
analyses after 106 electrocardiograms had been excluded
due to atrial fibrillation or flutter (n = 45), artificial
pacemaker (n = 18), >10% non-sinus beats (n = 27),
other abnormal rhythms (n = 4), or technical problems
during processing and analysis of electrocardiograms (n
= 12). For HR analyses, we used the mean value of the
second and third measurement.
All HRV variables were log-transformed before ana-
lyses because of their skewed distribution. Potential con-
founders were selected for adjustment based on directed
acyclic graphs (DAG) taking into account prior knowl-
edge regarding their associations with health behaviours
and HRV [36]. According to the resulting DAG, only
age had to be adjusted for in analyses of the association
of health behaviour with HRV (Figure 1). However,
especially in cross-sectional studies as our study a clear
temporal differentiation of cause and effect is impossi-
ble. We cannot separate the effect of health behaviour
on biomedical risk factors or diseases from the effect of
disease on behavioural and biomedical risk factors. For
example, we cannot distinguish whether physical inactiv-
ity has caused diabetes or vice versa. We therefore per-
formed several sensitivity analyses. For example, we
additionally calculated models with adjustment for
further potential confounders such as CVD, diabetes
mellitus, heart rate, hypertension, body mass index, edu-
cation, health behaviour, beta blockers, ACE inhibitors,
diuretic, calcium channel blockers and antiarrhythmic
agents.
Since categorization of originally continuous variables
does not use within-category information efficiently
[37], and non-linearities in the association of HRV and
health behaviours were anticipated, we fitted age-
adjusted generalized additive models (GAMs) [38].
GAMs can be used to check the assumption of the line-
arity of the relationship between HRV and health beha-
viours. For each smoothing effect in a model, a c2-test
comparing the deviance between the full model (includ-
ing age and the smoothed exposure variable) and the
model without the exposure variable was performed.
We calculated age-adjusted geometric means (± 95%
confidence interval (CI)) of HRV parameters by cate-
gories of health-behaviour variables using linear regres-
sion models. We calculated quartiles for physical-activity
indices and the dietary pattern index. For the consump-
tion of tobacco products and alcohol, zero consumption
was defined as the lowest category, and the remaining
subjects were categorized in tertiles. The F-test was
used to test the difference in adjusted means of HRV
between categories of health-behaviour variables.
To assess the influence of prevalent disease status, we
carried out sensitivity analyses of the association of
HRV with health behaviour in the whole population
(893 males and 778 females), as well as in a “healthy”
subgroup without prevalent CVD (defined as myocardial
infarction (MI), self-reported coronary artery bypass
graft, self-reported percutaneous transluminal coronary
angioplasty, self-reported physician-diagnosed stroke, or
carotid surgery), without diabetes mellitus (defined as
self-reported physician-diagnosed diabetes and/or use of
anti-diabetic medication) and without HRV-relevant
medication (beta-blockers, angiotensin-converting
enzyme (ACE) inhibitors, anti-arrhythmic drugs) (411
males and 363 females). The association of HRV with
MET-hours per week was analyzed in the subgroup of
participants who played sports.
Hypothesis tests were conducted at the significance
level of a = 0.01 to account for the problem of multiple
testing because each independent variable was tested for
its association with four HRV indices and heart rate. All
analyses were undertaken using SAS 9.1 (SAS Institute,
Cary, NC, USA).
Results
The baseline characteristics of the study population are
shown in Table 1. Overall, the study population showed
a high burden of cardiovascular risk factors and diseases.
Table 2 and Table 3 show the age-adjusted means of
HRV and HR by categories of health behaviour in the
total population. There was no consistent or statistically
significant association of dietary pattern, alcohol con-
sumption and physical activity with HRV in either sex.
However, males and females with a high sport index
and total activity index (fourth quartile) showed a signif-
icantly lower HR compared with other quartiles. Males
Figure 1 Directed acyclic graph (DAG) as the general basis of
the confounder selection for the statistical analysis. This DAG
resulted in simple age-adjusted models in the analysis of the
association of healthbehaviour with HRV. BP = Blood Pressure; BMI
= Body Mass Index; CVD = Cardiovascular Diseases; HR = Heart Rate;
*unmeasured; solid lines: potential confounder according to DAG;
dotted lines: there is no confounding according to DAG.
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who never smoked (zero packyears) had a significantly
lower HR, and higher SDNN, LF and LF/HF compared
with smokers with any accumulated packyears. However,
there was no dose-response relationship across tertiles
of packyears. No statistically significant association was
found with the number of currently smoked tobacco
products except for HR and LF/HF in males.
GAM analyses confirmed the association of SDNN
with packyears of smoking in both sexes (Figure 2) and
the association of HR with currently smoked tobacco
products and packyears in males. Furthermore, there
was a weak (but statistically significant) positive
association of sport index with HR, SDNN and with LF
power in males. No further statistically significant asso-
ciations between health behaviour indices and HRV
parameters were observed.
Analyses of the association of HRV with MET-hours
per week in participants performing sport showed no
significant association of SDNN, HF, and LF/HF with
MET-hours per week. However, a weak (but statistically
significant) association of MET-hours per week with LF
was observed in females (Figure 3).
To exclude the influence of prevalent diseases and
potential confounders on the association of behavioural
Table 1 Baseline characteristics of the CARLA study population (2002-2006)
Women (n = 812) Men (n = 967)
N Mean (Standard deviation) or
Proportion
N Mean (Standard deviation) or
Proportion
Age (yrs) 812 63.7 (9.9) 967 64.9 (10.2)
Heart rate 812 71.5 (10.6) 966 71.34 (12.4)
LDL/HDL-Quotient 807 2.4 (0.9) 960 2.8 (1.0)
Body mass index (kg/m2) 812 28.5 (5.4) 967 28.5 (4.1)
Waist-to-hip ratio (WHR) 812 0.9 (0.1) 967 1.0 (0.1)
Smoking:
Current 119 17.1% 225 27.6%
Past 140 18.1% 496 46.9%
Never 553 64.8% 245 25.5%
Packyears of tobacco products 812 4.3 (9.0) 964 15.6 (16.6)
Currently smoked no. of tobacco products/day 812 1.9 (5.4) 966 3.8 (8.8)
Alcohol consumption % >20 (female)/30 (male) g/day 32 4.5% 197 22.5%
Alcohol g/day 812 4.1 (7.1) 964 17.5 (18.67)
Sports: % active (any sports) 347 42.3% 296 31.3%
Sport-index 808 2.4 (0.7) 962 2.4 (0.7)
Leisure-time-index 810 3.1 (0.6) 966 3.1 (0.6)
MET-hours per week1 347 9.6 (7.6) 296 13.1 (10.4)
Dietary pattern index 812 16.4 (3.2) 965 14.5 (3.2)
Education (years of training):
<= 10 years 122 13.6% 36 4.2%
11-13 years 387 47.0% 391 42.0%
14-17 years 231 29.1% 335 32.7%
>= 18 years 72 10.2% 205 21.1%
Drug use:
Betablockers 279 33.2% 307 27.6%
ACE-Inhibitors 254 28.5% 340 30.2%
Disease prevalence:
Myocardial infarction (MI)2 17 1.9% 88 7.6%
Stroke 27 2.8% 42 3.5%
Cardiovascular Disease (CVD)3 48 5.2% 153 12.7%
Hypertension4 608 71.2% 789 78.7%
Diabetes mellitus5 120 13.1% 154 15.9%
1MET: metabolic equivalent
2MI: defined as self-reported physician-diagnosed myocardial infarction and/or definite MI by physician-validated Minnesota Code of the 10-second ECG
3CVD: including prevalent myocardial infarction, coronary artery bypass graft, percutaneous transluminal coronary angioplasty, stroke, carotid surgery
4Hypertension defined as SBP >= 140 and/or DBP >= 90 mmHg, and/or use of antihypertensive medication by ATC code
5Diabetes defined as self-reported physician-diagnosed diabetes mellitus and/or use of anti-diabetic medication by ATC code
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variables and HRV, we calculated age-adjusted models
in healthy subjects, and we calculated multivariate
adjusted models in the whole group (adjustment for age
and additionally for CVD, diabetes mellitus, HR, educa-
tion, hypertension, body mass index, beta blockers, ACE
inhibitors, diuretics, calcium-channel blockers and anti-
arrhythmic agents). However, there was no relevant
change in the association of behavioural variables with
HRV (data not shown).
Discussion
We aimed to provide population-based data on the
association of HRV with behavioural risk factors in an
elderly general population. We found only weak and
inconsistent associations of HRV with physical activity,
smoking, alcohol consumption and dietary pattern. To
our knowledge, the CARLA study is the largest
population-based study with such a comprehensive pro-
tocol to increase reliability and standardization of HRV
measurements. Our results thus add to the literature by
providing more reliable estimates of true HRV values.
This enables study of the associations between beha-
vioural factors and HRV with less bias due to measure-
ment error and variability in examination conditions.
A limitation of our analyses was its cross-sectional
nature, which hampers evaluation of causal inferences.
HRV was assessed simultaneously with prevalent disease
and health behaviour, so we cannot exclude the possibi-
lity that prevalent disease may have affected the levels of
health behaviour and HRV. We addressed this limitation
by conducting subgroup analyses in healthy subjects and
additionally by calculating multivariate adjusted models
in the whole group. However, we did not find relevant
changes in the lack of associations.
Table 2 Age-adjusted mean heart rate variability and heart rate by categories of health behavior in the female CARLA
study population
Heart rate SDNN LF/HF HF LF
Risk factor N Mean (95%CI) Mean (95%CI) Mean (95%CI) Mean (95%CI) Mean (95%CI)
Sports-index Q1 226 71.4 (70.1-72.7)† 27.6 (26.0-29.3) 1.0 (0.9-1.1) 162.7 (139.7-189.6) 166.3 (144.5-191.4)
Q2 193 73.3 (71.9-74.8) 28.1 (26.3-30.0) 1.1 (1.0-1.3) 154.3 (130.7-182.1) 174.9 (150.2-203.6)
Q3 143 71.1 (69.5-72.8) 28.1 (26.1-30.3) 1.0 (0.8-1.1) 175.1 (144.5-212.3) 172.0 (144.1-205.2)
Q4 212 70.2 (68.8-71.6) 28.4 (26.7-30.3) 1.0 (0.9-1.1) 179.3 (153.1-210.0) 178.8 (154.6-206.7)
Leisure time-index Q1 232 72.2 (70.9-73.5) 28.5 (26.8-30.2) 1.0 (0.9-1.2) 170.2 (146.2-198.1) 183.3 (159.5-210.7)
Q2 124 71.4 (69.6-73.2) 26.1 (24.0-28.3) 1.0 (0.9-1.2) 142.1 (115.4-174.9) 142.1 (117.5-172.0)
Q3 253 71.6 (70.3-72.9) 28.8 (27.2-30.5) 1.0 (0.9-1.1) 173.7 (150.2-200.9) 176.5 (154.5-201.7)
Q4 167 70.5 (68.9-72.1) 28.2 (26.2-30.2) 1.0 (0.9-1.2) 179.5 (149.9-214.8) 182.4 (154.6-215.1)
Total activity-index Q1 215 71.8 (70.4-73.1)† 28.0 (26.3-29.8) 1.0 (0.9-1.2) 163.1 (139.4-190.7) 169.3 (146.6-195.5)
Q2 140 74.0 (72.3-75.7) 27.5 (25.5-29.7) 1.1 (1.0-1.3) 148.7 (122.4-180.5) 171.2 (143.2-204.7)
Q3 194 70.7 (69.2-72.1) 27.3 (25.6-29.1) 1.0 (0.9-1.1) 162.5 (137.8-191.6) 165.8 (142.5-193.0)
Q4 224 70.4 (69.1-71.8) 29.1 (27.4-30.9) 1.0 (0.9-1.1) 189.4 (162.5-220.9) 183.9 (159.7-211.9)
No. of currently smoked
tobacco products/day
none 661 71.5 (70.7-72.3) 28.3 (27.3-29.3) 1.0 (0.9-1.1) 168.8 (154.2-184.8) 175.8 (161.8-191.0)
T1 37 70.9 (67.6-74.3) 27.5 (23.7-32.0) 1.3 (1.0-1.7) 153.8 (105.0-225.4) 196.6 (138.5-279.2)
T2 46 71.3 (68.3-74.4) 27.5 (24.0-31.5) 0.8 (0.6-1.1) 185.2 (131.2-261.4) 153.5 (111.9-210.7)
T3 34 74.3 (70.7-77.8) 26.8 (22.8-31.4) 0.9 (0.7-1.2) 154.8 (103.6-231.4) 144.9 (100.2-209.5)
Packyears of smoking none 482 72.1 (71.2-73.1) 28.3 (27.1-29.5) 1.1 (1.0-1.2) 164.4 (147.8-182.8) 176.9 (160.5-195.1)
T1 98 70.1 (68.1-72.2) 28.3 (25.8-31.0) 1.0 (0.9-1.2) 182.8 (144.7-230.9) 188.5 (152.2-233.6)
T2 100 70.7 (68.7-72.8) 28.0 (25.5-30.7) 1.0 (0.8-1.1) 173.2 (137.1-218.9) 168.5 (135.9-208.8)
T3 98 71.5 (69.5-73.6) 27.3 (24.9-30.0) 0.9 (0.8-1.1) 169.4 (133.8-214.5) 151.9 (122.4-188.7)
Alcohol (g/d) none 428 71.4 (70.4-72.4) 28.0 (26.8-29.3) 1.0 (0.9-1.1) 168.3 (150.4-188.4) 172.8 (155.9-191.6)
T1 91 73.9 (71.7-76.0) 27.6 (25.1-30.4) 1.0 (0.8-1.2) 168.0 (131.8-214.2) 169.0 (135.3-211.2)
T2 145 70.7 (69.0-72.4) 28.0 (25.9-30.2) 1.0 (0.9-1.2) 166.8 (137.5-202.3) 173.0 (144.9-206.5)
T3 114 71.9 (70.0-73.8) 29.1 (26.7-31.7) 1.1 (0.9-1.2) 170.7 (137.4-212.2) 183.1 (149.9-223.5)
Dietary pattern index Q1 215 71.4 (70.0-72.8) 30.0 (28.2-32.0) 1.1 (1.0-1.3) 188.2 (160.7-220.4) 210.9 (182.5-243.7)
Q2 191 72.1 (70.6-73.6) 26.9 (25.1-28.7) 1.1 (0.9-1.2) 144.8 (122.5-171.1) 155.2 (133.2-180.8)
Q3 176 71.1 (69.6-72.7) 27.6 (25.7-29.5) 1.0 (0.8-1.1) 165.8 (139.4-197.3) 159.0 (135.6-186.4)
Q4 196 71.8 (70.4-73.3) 27.8 (26.0-29.7) 1.0 (0.9-1.1) 174.9 (148.3-206.3) 170.3 (146.4-198.1)
Q1 = lowest quartile of health behavior, Q4 = highest quartile of health behavior; T1 = lowest tertile of health behavior (excluding non-consumer), T3 = highest
tertile of health behavior (excluding non-consumer); † p < 0.01, ‡ p < 0.001 (F-test for difference between respective categories of health behavior)
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Measurement of behavioural factors by question-
naire is susceptible to misclassification [39,40]. It can-
not be ruled out that the lack of association of
behavioural risk factors with HRV in the present
study occurred due to measurement error in self-
reported behaviours (particularly with respect to phy-
sical activity and dietary pattern). However, the used
questionnaires have been validated [30,33,41] and are
frequently used.
In general, comparison of the present HRV results
with the literature must be done cautiously because of
methodological differences. In particular, the wide range
of recording conditions of applied ECG as well as the
lengths and pre-processing steps used before spectral
analyses may result in considerable differences in the
HRV parameters themselves between studies. Further-
more, a limitation generally true for studies of HRV is
that spectral parameters are sensitive to several physio-
logical and environmental influences as well as to the
pre-processing protocol [42]. Moreover, within- and
between-subject reliability of HRV measurements can be
poor [43]. However, in the present study, environmental
conditions during ECG recording were controlled and
standardized to improve reliability.
Table 3 Age-adjusted mean heart rate variability and heart rate by categories of health behavior in the male CARLA
study population
Heart rate SDNN LF/HF HF LF
Risk factor N Mean (95%CI) Mean (95%CI) Mean (95%CI) Mean (95%CI) Mean (95%CI)
Sports-index Q1 243 72.6 (71.1-74.1) † 25.8 (24.2-27.6) 1.6 (1.4-1.8) 102.8 (87.1-121.2) 162.8 (140.7-188.3)
Q2 255 72.0 (70.5-73.5) 24.5 (23.0-26.1) 1.6 (1.4-1.8) 100.2 (85.3-117.8) 158.5 (137.5-182.8)
Q3 177 71.9 (70.1-73.7) 27.6 (25.6-29.8) 1.6 (1.4-1.8) 119.5 (98.4-145.1) 193.1 (162.7-229.1)
Q4 215 69.3 (67.7-70.9) 27.2 (25.4-29.2) 1.6 (1.4-1.8) 121.3 (101.7-144.6) 198.0 (169.5-231.2)
Leisure time-
index
Q1 181 71.5 (69.8-73.3) 25.6 (23.8-27.7) 1.5 (1.3-1.7) 113.6 (93.7-137.6) 166.1 (140.2-196.7)
Q2 234 73.1 (71.6-74.7) 26.0 (24.3-27.8) 1.7 (1.5-1.9) 104.2 (88.0-123.4) 173.1 (149.1-200.9)
Q3 269 70.1 (68.6-71.5) 26.1 (24.5-27.8) 1.5 (1.4-1.7) 111.6 (95.4-130.6) 172.8 (150.4-198.6)
Q4 208 71.3 (69.7-72.9) 26.6 (24.8-28.6) 1.7 (1.5-1.9) 108.8 (91.0-130.2) 188.1 (160.6-220.4)
Total activity-
index
Q1 182 73.6 (71.8-75.3) † 24.9 (23.1-26.8) 1.5 (1.3-1.7) 102.4 (84.6-124.0) 155.2 (131.1-183.6)
Q2 236 71.9 (70.4-73.5) 25.1 (23.5-26.8) 1.6 (1.5-1.8) 98.7 (83.5-116.8) 160.6 (138.5-186.3)
Q3 274 71.0 (69.5-72.4) 27.3 (25.7-29.0) 1.6 (1.4-1.7) 120.5 (103.2-140.9) 188.5 (164.4-216.3)
Q4 198 69.7 (68.0-71.3) 27.0 (25.1-29.0) 1.7 (1.5-1.9) 115.0 (95.8-138.2) 196.3 (167.0-230.8)
No. of
currently
smoked
tobacco
products/day
none 677 70.5 (69.6-71.4) ‡ 26.3 (25.3-27.3) 1.6 (1.5-1.8) † 108.8 (98.4-120.3) 178.7 (163.6-195.3)
T1 77 73.3 (70.6-76.0) 25.9 (23.1-29.1) 1.8 (1.5-2.1) 100.0 (74.5-134.2) 177.0 (136.5-229.5)
T2 89 73.9 (71.3-76.4) 24.9 (22.3-27.8) 1.5 (1.2-1.8) 106.7 (80.6-141.2) 161.2 (125.8-206.4)
T3 49 77.8 (74.3-81.2) 26.5 (22.8-30.8) 1.0 (0.8-1.3) 140.9 (96.6-205.5) 148.0 (106.1-206.6)
Packyears of
smoking
none 191 70.0 (68.3-71.7) † 29.2 (27.1-31.4) † 1.7 (1.5-2.0) † 134.3 (111.5-161.7) 232.6 (197.6-274.0) ‡
T1 237 70.9 (69.3-72.4) 26.0 (24.3-27.8) 1.7 (1.5-1.9) 104.5 (88.4-123.5) 176.2 (152.1-204.1)
T2 229 70.8 (69.3-72.4) 24.7 (23.1-26.4) 1.7 (1.5-1.9) 91.5 (77.2-108.5) 158.5 (136.5-184.0)
T3 233 73.8 (72.3-75.3) 25.3 (23.7-27.0) 1.3 (1.2-1.5) 115.9 (97.9-137.2) 152.7 (131.7-177.1)
Alcohol (g/d) none 190 71.4 (69.7-73.1) 25.7 (23.9-27.6) 1.4 (1.3-1.6) 109.9 (91.2-132.5) 159.1 (135.0-187.6)
T1 237 71.5 (70.0-73.1) 25.6 (23.9-27.3) 1.7 (1.5-1.9) 101.0 (85.4-119.5) 170.6 (147.2-197.9
T2 226 69.9 (68.3-71.5) 27.7 (25.9-29.6) 1.6 (1.4-1.8) 129.6 (109.2-153.8) 204.7 (176.0-238.0)
T3 237 72.7 (71.2-74.3) 25.6 (24.0-27.4) 1.7 (1.5-1.9) 101.0 (85.3-119.5) 168.6 (145.3-195.7)
Dietary
pattern index
Q1 252 72.2 (70.7-73.8) 25.1 (23.5-26.8) 1.5 (1.4-1.7) 105.6 (89.4-124.7) 164.0 (141.6-189.9)
Q2 215 71.6 (69.9-73.2) 27.6 (25.8-29.6) 1.7 (1.6-2.0) 116.4 (97.6-138.8) 204.2 (174.8-238.4)
Q3 194 72.1 (70.4-73.8) 25.6 (23.8-27.5) 1.7 (1.5-1.9) 100.1 (83.1-120.5) 169.9 (144.2-200.1)
Q4 230 70.0 (68.4-71.5) 26.3 (24.6-28.2) 1.4 (1.3-1.6) 115.1 (96.9-136.8) 166.5 (143.0-193.9)
Q1 = lowest quartile of health behavior, Q4 = highest quartile of health behavior; T1 = lowest tertile of health behavior (excluding non-consumer), T3 = highest
tertile of health behavior (excluding non-consumer); † p < 0.01, ‡ p < 0.001 (F-test for difference between respective categories of health behavior)
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Figure 2 SDNN (log transformed) in the total population by sex and health behaviour: a) by sport activity index, b) by alcohol
consumption, c) by currently smoked tobacco products, d) by ever smoked tobacco packyears, e) by dietary pattern index. Bars
represent age-adjusted SDNN means (± 95% CI) by categories of health behaviour variables, lines represent loess curves (± pointwise 95% CI), p-
values were calculated by c2-test comparing the deviance between the age-adjusted exposure model and the model without the exposure
variable.
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The literature is inconsistent with respect to the effect
of physical activity on HRV. Physical activity causes a
resting bradycardia that is thought to be partly due to
the higher vagal tone of HR, thus increasing in particu-
lar HF and total HRV power. Some studies showed a
positive association of physical activity with some or all
HRV measures examined [7,9,15,16,19,21,44], but others
did not [17,18]. A possible explanation for these con-
flicting results may be that, in studies showing no asso-
ciation of physical activity with HRV, the frequency,
duration and intensity of physical activity or physical
training may have been insufficient to increase vagal
regulation of HR. This interpretation is supported by
studies which showed that a short period of intense
aerobic training as well as long-term (but low-intensity)
endurance training did not cause any change in resting
HRV [18,45]. In contrast, a 6-month randomized trial of
moderate-intensity training (8 kcal/kg per week)
revealed increased HRV in post-menopausal sedentary
women [44]. A further explanation for conflicting results
might be that the effect of physical activity on HRV is
modified by age. Older subjects showed smaller effects
than younger ones, which might be due to a reduced
“trainability” of the heart [19]. However, our results
showed no modification of effects by age (data not
shown).
A methodological explanation for discrepant results
regarding physical activity and HRV might be that posi-
tive associations tended to be derived primarily from
long-term ECG recordings. This could be due to the
variability of current physical activity during long-term
ECG recording, which influences HRV measurements
particularly low-frequency HRV [46].
Numerous studies with different recording lengths of
ECG and different populations showed a negative asso-
ciation of smoking with various measures of HRV
[3,10-12,22-24], although significant effects were not
always observed for all HRV measures determined
[8,11,12,24] or for both sexes [20], or were not con-
firmed in multivariable analyses [8]. Stolarz et al. found
conflicting results for different populations [9], and no
association was observed in the Rotterdam Study [4]. In
the present study, we also did not find a clear pattern of
a smoking effect on HRV, and the observed effects of
smoking were mostly small. We assumed that current
HRV is mostly affected by current smoking, but we did
not find an association with the currently smoked num-
ber of tobacco products. In contrast, we found signifi-
cantly higher HRV in males who never smoked
compared with smokers with any accumulated pack-
years. This argues for a long-term effect of smoking on
autonomic function.
Findings regarding alcohol consumption and HRV are
inconsistent. Some authors reported a positive associa-
tion in women [22,26], but others found a negative asso-
ciation [10,11] or no association [4,23,25]. Our results
are in accordance with the latter findings. One problem
impeding real comparability of the studies is that alco-
hol consumption was defined differently across studies
with varying cutoff points for exposure classification.
Perhaps measures of patterns of alcohol consumption
(e.g., binge drinking) would be more relevant for the
association of HRV and CVD risk.
Only one study found an association of reduced HRV
with an “unhealthy eating pattern” - defined as frequent
consumption of white bread and full-fat milk (instead of
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Figure 3 LF (log transformed) by sex and health behaviour in participants who play sports (275 males and 332 females). Bars represent
age-adjusted LF means (± 95% CI) by categories of MET-hours per week, lines represent loess curves (± pointwise 95% CI), p-values were
calculated by c2-test comparing the deviance between the age-adjusted model and the model without the MET-hours per week variable.
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low-fat milk) and little consumption of fruits - in men
[10]. Several authors evaluated the effect of unsaturated
fatty acids on HRV [25,27,47]. Christensen et al. found a
positive association of SDNN with increased consump-
tion of fish [25]. However, a randomized trial of the
effect of the consumption of industrially produced
trans-fatty acids and n-3-unsaturated fatty acids on
HRV did not replicate this association [27]. In the
CARLA study, we did not find an association of HRV
with dietary pattern and with fish consumption.
A possible explanation of our overall results could be
that HRV is primarily determined by genetic factors
[48-50]. A recent study found that genetic factors
accounted for a major portion of the inter-individual
differences in HRV, and no single behavioural determi-
nant appeared to have a major influence on HRV [50].
Another possibility is that HRV is not a mediator of
the effect of behavioural risk factors on CVD, but
becomes effective after the stage of biomedical risk fac-
tors. Thus, it could just be a marker of ill health and
for prospective adverse health outcomes. HRV may
therefore have been found to be more strongly related
to those biomedical risk factors which have a high pre-
dictive power for future CVD events (e.g., diabetes and
obesity) [10,20].
Conclusion
We hypothesized that HRV is associated with beha-
vioural factors and therefore might be a mediator of
the effect of behavioural CVD risk factors on CVD
events, but this hypothesis was not confirmed by our
results. These findings support the interpretation that
there may be no true causal association of behavioural
factors with HRV, which is also compatible with the
inconsistent literature. However, a final conclusion as
to whether HRV is an intermediate on the causal path
or a marker of subclinical or impending disease cannot
be drawn on the basis of cross-sectional analyses. For-
tunately, the ongoing follow-up investigation of the
study subjects will give us the opportunity to examine
the prospective associations of behavioural risk factors
with HRV and incident events, and to assess correct
temporal relations.
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